226 related articles for article (PubMed ID: 25633035)
21. Early growth response genes 2 and 3 induced by AP-1 and NF-κB modulate TGF-β1 transcription in NK1.1
Han S; Zhu T; Ding S; Wen J; Lin Z; Lu G; Zhang Y; Xiao W; Ding Y; Jia X; Chen H; Gong W
Cell Signal; 2020 Dec; 76():109800. PubMed ID: 33011290
[TBL] [Abstract][Full Text] [Related]
22. Nemo-like kinase as a negative regulator of nuclear receptor Nurr1 gene transcription in prostate cancer.
Wang J; Yang ZH; Chen H; Li HH; Chen LY; Zhu Z; Zou Y; Ding CC; Yang J; He ZW
BMC Cancer; 2016 Mar; 16():257. PubMed ID: 27036119
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-6 -572G/C polymorphism and prostate cancer susceptibility.
Huang WJ; Wu LJ; Min ZC; Xu LT; Guo CM; Chen ZP; Lou XJ; Xu B; Lv BD
Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706719
[TBL] [Abstract][Full Text] [Related]
24. C/EBPbeta regulates metastatic gene expression and confers TNF-alpha resistance to prostate cancer cells.
Kim MH; Minton AZ; Agrawal V
Prostate; 2009 Sep; 69(13):1435-47. PubMed ID: 19489038
[TBL] [Abstract][Full Text] [Related]
25. A Paracrine Role for IL6 in Prostate Cancer Patients: Lack of Production by Primary or Metastatic Tumor Cells.
Yu SH; Zheng Q; Esopi D; Macgregor-Das A; Luo J; Antonarakis ES; Drake CG; Vessella R; Morrissey C; De Marzo AM; Sfanos KS
Cancer Immunol Res; 2015 Oct; 3(10):1175-84. PubMed ID: 26048576
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-6 activates PI3K/Akt pathway and regulates cyclin A1 to promote prostate cancer cell survival.
Wegiel B; Bjartell A; Culig Z; Persson JL
Int J Cancer; 2008 Apr; 122(7):1521-9. PubMed ID: 18027847
[TBL] [Abstract][Full Text] [Related]
27. Association of common polymorphisms in inflammatory genes interleukin (IL)6, IL8, tumor necrosis factor alpha, NFKB1, and peroxisome proliferator-activated receptor gamma with colorectal cancer.
Landi S; Moreno V; Gioia-Patricola L; Guino E; Navarro M; de Oca J; Capella G; Canzian F;
Cancer Res; 2003 Jul; 63(13):3560-6. PubMed ID: 12839942
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-30 subverts prostate cancer-endothelium crosstalk by fostering angiogenesis and activating immunoregulatory and oncogenic signaling pathways.
Ciummo SL; Sorrentino C; Fieni C; Di Carlo E
J Exp Clin Cancer Res; 2023 Dec; 42(1):336. PubMed ID: 38087324
[TBL] [Abstract][Full Text] [Related]
29. Activated signal transducers and activators of transcription 3 signaling induces CD46 expression and protects human cancer cells from complement-dependent cytotoxicity.
Buettner R; Huang M; Gritsko T; Karras J; Enkemann S; Mesa T; Nam S; Yu H; Jove R
Mol Cancer Res; 2007 Aug; 5(8):823-32. PubMed ID: 17699108
[TBL] [Abstract][Full Text] [Related]
30. EGR3-HDAC6-IL-27 Axis Mediates Allergic Inflammation and Is Necessary for Tumorigenic Potential of Cancer Cells Enhanced by Allergic Inflammation-Promoted Cellular Interactions.
Kwon Y; Kim M; Kim Y; Jeong MS; Jung HS; Jeoung D
Front Immunol; 2021; 12():680441. PubMed ID: 34234781
[TBL] [Abstract][Full Text] [Related]
31. Induction of IGF-1R expression by EGR-1 facilitates the growth of prostate cancer cells.
Ma Y; Cheng Q; Ren Z; Xu L; Zhao Y; Sun J; Hu S; Xiao W
Cancer Lett; 2012 Apr; 317(2):150-6. PubMed ID: 22115966
[TBL] [Abstract][Full Text] [Related]
32. Early growth response gene 1 is essential for urban particulate matter-induced inflammation and mucus hyperproduction in airway epithelium.
Xu F; Cao J; Luo M; Che L; Li W; Ying S; Chen Z; Shen H
Toxicol Lett; 2018 Sep; 294():145-155. PubMed ID: 29787794
[TBL] [Abstract][Full Text] [Related]
33. Radioresistance of Stat1 over-expressing tumour cells is associated with suppressed apoptotic response to cytotoxic agents and increased IL6-IL8 signalling.
Efimova EV; Liang H; Pitroda SP; Labay E; Darga TE; Levina V; Lokshin A; Roizman B; Weichselbaum RR; Khodarev NN
Int J Radiat Biol; 2009 May; 85(5):421-31. PubMed ID: 19437244
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors.
Eliopoulos AG; Stack M; Dawson CW; Kaye KM; Hodgkin L; Sihota S; Rowe M; Young LS
Oncogene; 1997 Jun; 14(24):2899-916. PubMed ID: 9205097
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-8 is a molecular determinant of androgen independence and progression in prostate cancer.
Araki S; Omori Y; Lyn D; Singh RK; Meinbach DM; Sandman Y; Lokeshwar VB; Lokeshwar BL
Cancer Res; 2007 Jul; 67(14):6854-62. PubMed ID: 17638896
[TBL] [Abstract][Full Text] [Related]
36. Neuregulin1 signaling targets SRF and CREB and activates the muscle spindle-specific gene Egr3 through a composite SRF-CREB-binding site.
Herndon CA; Ankenbruck N; Lester B; Bailey J; Fromm L
Exp Cell Res; 2013 Mar; 319(5):718-30. PubMed ID: 23318675
[TBL] [Abstract][Full Text] [Related]
37. IL37 dampens the IL1β-induced catabolic status of human OA chondrocytes.
van Geffen EW; van Caam AP; van Beuningen HM; Vitters EL; Schreurs W; van de Loo FA; van Lent PL; Koenders MI; Blaney Davidson EN; van der Kraan PM
Rheumatology (Oxford); 2017 Mar; 56(3):351-361. PubMed ID: 27940589
[TBL] [Abstract][Full Text] [Related]
38. Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways.
Park JI; Lee MG; Cho K; Park BJ; Chae KS; Byun DS; Ryu BK; Park YK; Chi SG
Oncogene; 2003 Jul; 22(28):4314-32. PubMed ID: 12853969
[TBL] [Abstract][Full Text] [Related]
39. IκB-Kinase-epsilon (IKKε) over-expression promotes the growth of prostate cancer through the C/EBP-β dependent activation of IL-6 gene expression.
Péant B; Gilbert S; Le Page C; Poisson A; L'Ecuyer E; Boudhraa Z; Bienz MN; Delvoye N; Saad F; Mes-Masson AM
Oncotarget; 2017 Feb; 8(9):14487-14501. PubMed ID: 27577074
[TBL] [Abstract][Full Text] [Related]
40. Anti-inflammatory effect of Marchantin M contributes to sensitization of prostate cancer cells to docetaxel.
Niu L; Deng J; Zhu F; Zhou N; Tian K; Yuan H; Lou H
Cancer Lett; 2014 Jun; 348(1-2):126-34. PubMed ID: 24680871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
